As a member-owned Cooperative that strives to provide services that enhance the value and quality of members’ pharmacy benefits, a decision was made to bring specialty prior authorizations (PA) in-house, effective January 1, 2023.
First launched in 2003, Humira has experienced more than two decades of unprecedented marketplace dominance. A mainstay of treatment for several autoimmune conditions, National CooperativeRx’s members spend more on this drug than any other under the pharmacy benefit.
As the year of the dragon readies to swoop in, the year of the rabbit hops to an end. Astrological signs aside, the future of
The importance of fiduciary duties under the Employee Retirement Income Security Act of 1974 (ERISA) first came to light with respect to employer-sponsored retirement plans.
The Employee Retirement Income Security Act of 1974 (ERISA) provides private employers and individuals covered by employer-sponsored retirement and health plans with certain protections codified
National CooperativeRx is approaching its 20th year of delivering substantial pharmacy benefit savings to employers who self-fund employee benefits. Our milestone anniversary prompts us to
October is National Cooperative Month, a time when cooperatives nationwide raise awareness about their reliable and empowering approaches to providing services to diverse communities. For
Glucagon-like peptide 1 (GLP-1s) are a class of medications used to treat diabetes that can also lead to weight loss. Since 2021, GLP-1s have been
Employers and plan sponsors continue to seek valuable, cost-saving pharmacy benefit solutions for their plan participants. A common consideration for self-funded employer groups, and sometimes
Pharmacy benefit managers (PBMs) work behind the scenes to fulfill employer groups’ prescription drug needs. First, PBMs negotiate agreements with drug manufacturers, wholesalers, and pharmacies
The Departments of Treasury and Labor, Health and Human Services have provided further guidance on gag clause provisions within the private health insurance and public
State legislators around the country continue to introduce bills to force health plans to count drug coupon value provided by pharmaceutical companies towards patient out-of-pocket